Heart Failure Clinical Trial

Accuracy of Cardiac Acoustic Biomarkers Recorded by the Wearable Cardioverter Defibrillator

Summary

Evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) as compared to the AUDICOR AM acoustic cardiography recorder.

View Full Description

Full Description

Single arm, prospective, non significant risk device study to evaluate data accuracy of cardiac acoustic biomarkers (CABs) recorded by the Wearable Cardioverter Defibrillator (WCD) compared with the CABs data simultaneously recorded by an acoustic cardiography recorder, the AUDICOR AM device.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

18 years of age or older
heart failure or a history of heart failure
ischemic or non-ischemic cardiomyopathy
ejection Fraction less than or equal to 40% as measured within the last 6 months

Exclusion Criteria:

implanted left ventricular assist device
pacemaker dependency
currently hospitalized
atrial fibrillation on their last ECG or having an irregularly irregular pulse

Study is for people with:

Heart Failure

Estimated Enrollment:

60

Study ID:

NCT04292405

Recruitment Status:

Recruiting

Sponsor:

Zoll Medical Corporation

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

MAYO Clinic
Rochester Minnesota, 55905, United States More Info
Principal Investigator
Contact

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

60

Study ID:

NCT04292405

Recruitment Status:

Recruiting

Sponsor:


Zoll Medical Corporation

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.